-
By Jonathan Abrams, MD
Professor of Medicine, Division of Cardiology, University of New Mexico, Albuquerque
Dr. Abrams serves on the speakers bureau for Merck, Pfizer, and Parke-Davis.
Synopsis: In order to reduce CVD mortality, more active management and prevention of diabetes is needed.
Source: Hu G, et al. The Gender-Specific Impact of Diabetes and Myocardial Infarction at Baseline and During Follow-Up on Mortality From All Causes and Coronary Heart Disease. J Am Coll Cardiol. 2005;45:1413-1418.
-
By Michael H. Crawford, MD
Synopsis: Higher BNP levels predict worse outcomes under medical management and may be useful for decisions regarding surgery.
Source: Detaint D, et al. B-Type Natriuretic Peptide in Organic Mitral Regurgitation. Circulation. 2005;111:2391-2397.
-
Professor of Medicine, Chief of Clinical Cardiology, University of California, San Francisco
Synopsis: The beneficial effects of drug-eluting stents on coronary artery lumen enhancement are preserved for 4 years after implantation.
Source: Sousa JE, et al. Four-Year Angiographic and Intravascular Ultrasound Follow-Up of Patients Treated with Sirolimus-Eluting Stents. Circulation. 2005:111:2326-29.
-
By John P. DiMarco, MD, PhD
Professor of Medicine, Division of Cardiology, University of Virginia, Charlottesville
Dr. DiMarco is a consultant for Novartis and does research for Medtronic and Guidant.
Synopsis: Pulmonary vein isolation is a feasible first-line approach for this treatment of selected patients with symptomatic atrial fibrillation.
Source: Wazni OM, et.al. Radiofrequency Ablation vs Antiarrhthymic Drugs as First-Line Treatment of Symptomatic Atrial Fibrillation: A Randomized Trial. JAMA. 2005;
293:2634-2640.
-
Rifamixin, a nonabsorbed oral antibiotic, is effective for preventing traveler's diarrhea, according to new research.
-
-
By Alan Z. Segal, MD
Assistant Professor, Department of Neurology, Weill Cornell Medical College, and Attending Neurologist at NewYork-Presbyterian Hospital
Dr. Segal is on the speakers bureau of Boehringer-Ingelheim.
Synopsis: There was an increased incidence of injection site reactions among vaccine treated patients, but no difference in the incidence of serious adverse events.
-
By Michael Rubin, MD
Professor of Clinical Neurology at NewYork-Presbyterian Hospital, Cornell Campus
Dr. Rubin is on the speakers bureau for Athena Diagnostics and does research for Pfizer and Merck.
-
By M. Flint Beal, MD
Professor and Chairman of the Department of Neurology at Cornell Medical College
Dr. Beal reports no consultant, stockholder, speakers bureau, research, or other relationships related to this field of study.
-
By Claire Henchcliffe, MD
Assistant Professor of the Department of Neurology at Weill Medical College, Cornell University
Dr. Henchcliffe is on the speakers bureau for GlaxoSmithKline, Teva/Eisai, and Boehringer Ingelheim.
Synopsis: Depression and anxiety in Parkinsons disease might be associated with a specific loss of dopamine and noradrenaline innervation in the limbic system.
